Related Experiment Video
Updated: Jun 3, 2026

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
miR-146a is a pleiotropic regulator of motor neuron degeneration
Dylan A Galloway1, Hunter L Patterson1, Mariah L Hoye1
1Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
Abstract:
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. Here, we have profiled motor neuron microRNAs (miRNAs) during motor neuron degeneration in vivo to gain a better understanding of ALS pathophysiology. We demonstrate that one miRNA, miR-146a, is downregulated in diseased motor neurons despite upregulation in bulk tissue. Genetic deletion of miR-146a significantly extended survival in SOD1G93A mice with heterozygous animals demonstrating the largest benefit. A corresponding reduction in spinal cord gliosis but not motor neuron loss was observed. Finally, we observed that a proportion of miR-146a knockout animals develop spontaneous paralysis, motor neuron loss and chronic neuroinflammation with advanced age. Together these findings demonstrate that a single miRNA influences multiple aspects of motor neuron disease and highlights the complex role for neuroinflammation in ALS pathogenesis.
Insights
MicroRNA-146a (miR-146a) is crucial in Amyotrophic Lateral Sclerosis (ALS). Deleting miR-146a in mice extended survival and reduced spinal cord gliosis, revealing its complex role in neuroinflammation.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease impacting motor neurons.
- Understanding the molecular mechanisms underlying ALS pathophysiology is critical for developing effective treatments.
Purpose of the Study:
- To profile microRNAs (miRNAs) in motor neurons during ALS progression in vivo.
- To investigate the specific role of miR-146a in ALS pathogenesis and its impact on neuroinflammation.
Main Methods:
- Profiling of motor neuron miRNAs in a mouse model of ALS (SOD1G93A).
- Genetic deletion of miR-146a in SOD1G93A mice to assess its functional impact.
- Evaluation of survival rates, motor neuron loss, and spinal cord gliosis.
Main Results:
- miR-146a was found to be downregulated in diseased motor neurons, contrasting with its upregulation in bulk tissue.
- Genetic deletion of miR-146a significantly extended survival in SOD1G93A mice, with heterozygous deletion showing the most benefit.
- Reduced spinal cord gliosis was observed in miR-146a knockout animals, though motor neuron loss was not significantly affected.
- A subset of miR-146a knockout mice developed spontaneous paralysis, motor neuron loss, and chronic neuroinflammation with age.
Conclusions:
- A single miRNA, miR-146a, influences multiple facets of motor neuron disease.
- The findings highlight the intricate role of neuroinflammation in ALS pathogenesis and suggest miR-146a as a potential therapeutic target.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
Satellite Stem Cells and Muscular Dystrophy

